43 results
PRE 14A
SHPH
Shuttle Pharmaceuticals Holdings Inc
10 Jun 24
Preliminary proxy
6:12am
stock as and when desired and we believe our ability to maintain analyst coverage, attractive investor interest, and have access to capital may become … . Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting
424B3
SHPH
Shuttle Pharmaceuticals Holdings Inc
22 Mar 24
Prospectus supplement
6:07am
therapeutics has become an increasing priority for U.S. payors, especially with the advent of biologics. Payors (and market access agencies in the EU … treatment guidelines, such as those from the NCCN (National Comprehensive Cancer Network), are expected to be used by private payors to limit the access
8-K
EX-10.2
k0k2d
13 Feb 24
Shuttle Pharma Announces Its Intent to Pursue a Rights Offering
8:00am
8-K
EX-10.1
pq8zs ikyrr9
30 Oct 23
Shuttle Pharma Advances Prostate Cancer Predictive Biomarker Program Through Exclusive License Agreement
5:14pm
424B3
wk32k
24 Aug 23
Prospectus supplement
2:00pm
8-K
EX-10.1
8ofld zvp5
5 Jun 23
Entry into a Material Definitive Agreement
8:10am
8-K
EX-99.1
ihb350 28s3
17 May 23
Shuttle Pharmaceuticals to Participate in the Lytham Partners Spring 2023 Investor Conference
9:00am
S-8
879zd7 6oajy
12 Dec 22
Registration of securities for employees
4:23pm
DEF 14A
tbrighd2ut pwkxzgu
21 Nov 22
Definitive proxy
5:28pm
8-K
EX-10.1
ig47 4hps8652lmpp9
1 Nov 22
Shuttle Pharmaceuticals Appoints Bette Jacobs to its Board of Directors
9:00am
DRS
m3nqmosp gfg6fv
29 Sep 22
Draft registration statement
12:00am
424B4
s4lr1g xuei5ekq64
31 Aug 22
Prospectus supplement with pricing info
6:16am